Intestinal Obstruction Terminated Phase 2 Trials for Lanreotide (DB06791)
Also known as: Obstruction Bowel / Bowel Obstruction / Other intestinal obstruction / Unspecified intestinal obstruction / Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction / Obstruction intestinal / Intestinal obstruction (disorder) / Intestinal obstruction NOS
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031423 (Intestinal Obstruction) | Terminated | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02365584 | Quality of Life in Patients With Inoperable Malignant Bowel Obstruction | Supportive Care |